Abstract
Objectives
Patients with acute coronary syndrome (ACS) should be referred promptly to the hospital to reduce mortality and morbidity. Differentiating between low-risk and high-risk patients remains a diagnostic challenge. Point-of-care testing can contribute to earlier disposition decisions for patients excluded from ACS. This study describes the validation of the Atellica® VTLi. Patient-side Immunoassay Analyzer for high-sensitivity troponin point-of-care (POC) analysis. (The Atellica VTLi is not available for sale in the USA. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed).
Methods
A total of 152 patients with acute chest pain admitted at the cardiac emergency department (ED) were included in the study. Capillary blood was compared with a whole blood and plasma sample obtained by venipuncture. All samples were analyzed using the Atellica VTLi Patient-side Immunoassay Analyzer; in addition, plasma was analyzed by a central lab immunoassay analyzer.
Results
No significant difference was observed between venous whole blood vs. plasma analyzed by the Atellica VTLi Patient-side Immunoassay Analyzer. The difference between capillary blood and venous blood showed a constant bias of 7.1%, for which a correction factor has been implemented. No clinically relevant differences were observed for the capillary POC results compared to plasma analyzed with a standard immunoassay analyzer.
Conclusions
The Atellica VTLi Patient-side Immunoassay Analyzer for high-sensitivity troponin analysis shows equivalent results for all sample types, including capillary blood. No clinically relevant discordances were observed between capillary POC and central laboratory results. With additional studies, this could pave the way towards rapid testing of high-sensitivity troponin in the ambulance or the general practitioner’s office without the need for hospitalization of patients with acute chest pain.
-
Research funding: Femke de Theije and Daniëlle Kemper are employed by Siemens Healthineers.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The study was approved by the local Medical Ethical Committee (METC Maastricht) and was executed according to the World Medical Association Declaration of Helsinki.
References
1. Hoorweg, BB, Willemsen, RT, Cleef, LE, Boogaerts, T, Buntinx, F, Glatz, JF, et al.. Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses. Heart 2017;103:1727–32. https://doi.org/10.1136/heartjnl-2016-310905.Search in Google Scholar PubMed
2. Plat, FM, Peters, YAS, Loots, FJ, de Groot, CJA, Eckhardt, T, Keizer, E, et al.. Ambulance dispatch versus general practitioner home visit for highly urgent out-of-hours primary care. Fam Pract. 2018;35:440–5. https://doi.org/10.1093/fampra/cmx121.Search in Google Scholar PubMed
3. Backus, BE, Tolsma, RT, Boogers, MJ. The new era of chest pain evaluation in The Netherlands. Eur J Emerg Med 2020;27:243–4. https://doi.org/10.1097/mej.0000000000000711.Search in Google Scholar PubMed
4. Bösner, S, Becker, A, Haasenritter, J, Abu Hani, M, Keller, H, Sönnichsen, AC, et al.. Chest pain in primary care: epidemiology and pre-work-up probabilities. Eur J Gen Pract 2009;15:141–6. https://doi.org/10.3109/13814780903329528.Search in Google Scholar PubMed
5. Webster, R, Norman, P, Goodacre, S, Thompson, A. The prevalence and correlates of psychological outcomes in patients with acute non-cardiac chest pain: a systematic review. Emerg Med J. 2012;29:267–73. https://doi.org/10.1136/emermed-2011-200526.Search in Google Scholar PubMed
6. Eslick, GD, Talley, NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Aliment Pharmacol Ther 2004;20:909–15. https://doi.org/10.1111/j.1365-2036.2004.02175.x.Search in Google Scholar PubMed
7. Alghamdi, A, Alotaibi, A, Alharbi, M, Reynard, C, Body, R. Diagnostic performance of prehospital point-of-care troponin tests to rule out acute myocardial infarction: a systematic review. Prehosp Disaster Med 2020;35:567–73. https://doi.org/10.1017/s1049023x20000850.Search in Google Scholar
8. Wilke, P, Masuch, A, Fahron, O, Zylla, S, Leipold, T, Petersmann, A. Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department. PLoS One 2017;12:e0188706. https://doi.org/10.1371/journal.pone.0188706.Search in Google Scholar PubMed PubMed Central
9. Haasenritter, J, Donner-Banzhoff, N, Bösner, S. Chest pain for coronary heart disease in general practice: clinical judgement and a clinical decision rule. Br J Gen Pract 2015;65:e748–53. https://doi.org/10.3399/bjgp15x687385.Search in Google Scholar
10. Harskamp, RE, Kleton, M, Smits, IH, Manten, A, Himmelreich, JCL, van Weert, HCPM, et al.. Performance of a simplified HEART score and HEART-GP score for evaluating chest pain in urgent primary care. Neth Heart J 2021;29:338–47. https://doi.org/10.1007/s12471-020-01529-4.Search in Google Scholar PubMed PubMed Central
11. Poldervaart, JM, Reitsma, JB, Backus, BE, Koffijberg, H, Veldkamp, RF, Ten Haaf, ME, et al.. Effect of using the heart score in patients with chest pain in the emergency department: a stepped-wedge, cluster randomized trial. Ann Intern Med 2017;166:689–97. https://doi.org/10.7326/m16-1600.Search in Google Scholar PubMed
12. Aarts, GWA, Mol, JQ, Camaro, C, Lemkes, J, van Royen, N, Damman, P. Recent developments in diagnosis and risk stratification of non-ST-elevation acute coronary syndrome. Neth Heart J 2020;28:88–92. https://doi.org/10.1007/s12471-020-01457-3.Search in Google Scholar PubMed PubMed Central
13. Mahler, SA, Hiestand, BC, Goff, DCJr, Hoekstra, JW, Miller, CD. Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events? Crit Pathw Cardiol 2011;10:128–33. https://doi.org/10.1097/hpc.0b013e3182315a85.Search in Google Scholar PubMed PubMed Central
14. Koper, LH, Frenk, LDS, Meeder, JG, van Osch, FHM, Bruinen, AL, Janssen, MJW, et al.. Urgent 1.5: diagnostic accuracy of the modified HEART score, with fingerstick point-of-care troponin testing, in ruling out acute coronary syndrome. Neth Heart J 2021;30. https://doi.org/10.1007/s12471-021-01646-8.Search in Google Scholar PubMed PubMed Central
15. Christenson, RH, Frenk, LDS, Graaf, HJ, TSYv, D, Wijnands, FPG, Foolen, HWJ, et al.. High sensitivity cardiac troponin I measurements at point-of-care: roadmap for analytical characterization and validation of lithium heparin plasma and whole blood matrices. J Appl Lab Med 2022. Online ahead of print.10.1093/jalm/jfac028Search in Google Scholar PubMed
16. Abbott Laboratories, LB, . ARCHITECT STAT High Sensitive Troponin-I [package insert]. IL, USA: ABBOTT; 2018.(G97079R01).Search in Google Scholar
© 2022 Walter de Gruyter GmbH, Berlin/Boston
